Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA
- 1 October 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 112 (7) , 2917-2926
- https://doi.org/10.1182/blood-2007-12-130823
Abstract
The histone deacetylase inhibitor SAHA enhances cell death stimulated by the proteasome inhibitor bortezomib (BZ) by disrupting BZ-induced aggresome formation. Here we report that Myc regulates the sensitivity of multiple myeloma (MM) cells to BZ + SAHA–induced cell death. In MM cells, Myc expression directly correlated with intracellular ER content, protein synthesis rates, the percentage of aggresome-positive cells, and the sensitivity to BZ + SAHA–induced cell death. Accordingly, Myc knockdown markedly reduced the sensitivity of MM cells to BZ + SAHA–mediated apoptosis. Furthermore, activation of Myc was sufficient to provoke aggresome formation and thus sensitivity to BZ + SAHA, and these responses required de novo protein synthesis. BZ + SAHA–mediated stimulation of apoptosis includes the induction of the proapoptotic BH3-only protein Noxa as well as endoplasmic reticular stress, a disruption of calcium homeostasis, and activation of capase-4. Finally, knockdown studies demonstrated that both caspase-4 and Noxa play significant roles in Myc-driven sensitivity to BZ + SAHA–induced apoptosis. Collectively, our results establish a mechanistic link between Myc activity, regulation of protein synthesis, increases in HDAC6 expression and aggresome formation, induction of Noxa, and sensitivity to BZ + SAHA–induced apoptosis. These data suggest that MM patients with elevated Myc activity may be particularly sensitive to the BZ + SAHA combination.Keywords
This publication has 42 references indexed in Scilit:
- Myc pathways provoking cell suicide and cancerOncogene, 2003
- The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571Blood, 2003
- c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XLMolecular and Cellular Biology, 2003
- Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts.2003
- Proteasome inhibitors disrupt the unfolded protein response in myeloma cellsProceedings of the National Academy of Sciences, 2003
- A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cellsProceedings of the National Academy of Sciences, 2003
- Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.2002
- Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumorsBlood, 2001
- c-Myc enhances protein synthesis and cell size during B lymphocyte developmentProceedings of the National Academy of Sciences, 1999
- The role of c-myc in cellular growth controlOncogene, 1999